Intervention

Referral

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting2

Common conditions15

Lead sponsors shown4

Clinical trials

5 shown

A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer SurvivorsNCT07699991 · 2026-09-01

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT TrialNCT07202247 · 2025-11-05

Prehabilitation for Improving Outcomes in Breast Cancer Patients Undergoing Neoadjuvant Systemic Treatment and SurgeryNCT07819981 · 2027-02-24

NOT_YET_RECRUITING

Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer SurvivorsNCT06654245 · 2025-06-11

Transform: Teaching, Technology, and TeamsNCT05572814 · 2022-09-30

Common conditions

Anatomic Stage 0 Breast Cancer AJCC v81 Anatomic Stage I Breast Cancer AJCC v81 Anatomic Stage II Breast Cancer AJCC v81 Anatomic Stage III Breast Cancer AJCC v81 Atrial Fibrillation1 Breast Carcinoma1 Heart Failure1 Localized Breast Carcinoma1 Prostate Carcinoma1 Recurrent Prostate Carcinoma1 Stage I Lung Cancer1 Stage II Lung Cancer1 Stage III Lung Cancer1 Stage IV Lung Cancer1 Type 2 Diabetes1

Leading sponsors

City of Hope Medical Center2 American College of Cardiology1 Ohio State University Comprehensive Cancer Center1 Wake Forest University Health Sciences1

Trial status mix

RECRUITING2

NOT_YET_RECRUITING1

TERMINATED1

UNKNOWN1

Phase mix

NA4

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.